Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy
/in International Publications, Malignant Melanoma /von 2005-11-26 / Cancer Immunol. Immunother. 2006 Aug;55(8):1011-6Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells
/in Colorectal Cancer, International Publications /von 2005-11-20 / Int. J. Cancer 2005 Nov;117(4):587-95Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer
/in Dendritic Cells, Hyperthermia, International Publications /von 2005-11-15 / Immunol. Lett. 2006 Mar;103(2):142-8Immunological treatment of liver tumors
/in Hepatocellular Carcinoma, International Publications /von 2005-11-14 / World J. Gastroenterol. 2005 Nov;11(42):6571-6Prostate cancer immunology: biology, therapeutics, and challenges
/in International Publications, Prostate Cancer /von 2005-11-10 / J. Clin. Oncol. 2005 Nov;23(32):8262-9Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity
/in International Publications, Malignant Melanoma /von 2005-11-01 / Clin. Cancer Res. 2005 Nov;11(21):7692-9Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer
/in International Publications, Pancreatic Cancer /von 2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6A):3709-14Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6B):4225-30Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile
/in Hyperthermia, International Publications, Prostate Cancer /von 2005-11-01 / Int J Hyperthermia 2005 Nov;21(7):649-56
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de